Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fu...(2006 ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
Date:2/9/2009
2006 ---- Qtr 1 Qtr 2 Qtr 3 Qtr 4 Year ----- ----- ----- ----- ---- Clinical Diagnostics: Chemistry and Clinical Automation $163.9 $175.3 $180.9 $196.1 $716.2 Cellular Analysis 184.0 196.6 202.8 223.0 806.4 Immunoassay and Molecular Diagnostics 119.4 131.2 127.4 140.4 518.4 ----- ----- ----- ----- ----- Total Clinical Diagnostics 467.3 503.1 511.1 559.5 2,041.0 ----- ----- ----- ----- ------- Life Sciences 101.7 113.2 120.1 152.5 487.5 ----- ----- ----- ----- ----- Total revenues $569.0 $616.3 $631.2 $712.0 $2,528.5 ====== ====== ====== ====== ======== (1) Amounts may not foot due to rounding. BECKMAN COULTER, INC. REVENUES BY GEOGRAPHY (1) (in millions) (unaudited) Quarter Ended December 31, Constant ------------ Reported Currency 2008 2007 Growth % Growth % ---- ---- -------- -------- Revenues by geography: United States $408.7 $380.6 7.4% 7.4% Europe 175.2 177.6 (1.3)% 8.3% Emerging Markets (2) 73.2 67.9 7.9% 18.
'/>"/>
| SOURCE Beckman Coulter - IR Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
Post Your Comments:
(Date:11/20/2009)... , SEATTLE, Nov. 20 /PRNewswire-FirstCall/... CTIC) announced today that the Ninth Circuit Cour...and ruled that CTI should be allowed to pursue all... case back to the District Court for trial. CTI f...mer third-party reimbursement consultant for CTI,s...
(Date:11/19/2009)... , COPENHAGEN, Nov. 19 Danish P...con cellulosic ethanol plant in Kalundborg, Denmar...of the world,s first and largest 2nd generation et...llerase enzymes are used in the plant,s innovative... Division of Danisco, was the first to market with...
(Date:11/19/2009)... , NEW YORK, Nov. 19 ... that it has sent the following letter to its shar... October 30, 2009, of China Biopharmaceuticals Hol...al company based in the People,s Republic of China...est in Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s...
(Date:11/19/2009)... , MONTREAL, Nov. 19 /PRNewswire/ - Aegera The...irst patient in a randomized Phase 2B study of AEG...ge development for multiple oncology indications. ...d Phase 2 Study of the X-Linked Inhibitor of Apopt...n with High-dose Cytarabine and Idarubicin in AML ...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2[0] Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group[0] DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel[0] NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company[0] Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML)
...n Show,s History Draws Participants From A Broad R...ate , , SAN FRANCISCO, Jan. 29 The 2009 edition ...oors Wednesday with attendance expected to be ,on ...hibition & conference, which is the largest ev...featuring an expanded program to address the busin...
...ThermoGenesis,Corp. (Nasdaq: KOOL ), a leading s...ore adult stem cells, announced today it will repo... ended December 31, 2008, on Wednesday, February,4...t , Management will host a conference call Wed...PM Eastern) to review the fiscal second quarter fi...
...tion Is Selected for Industry Leader LESS Panel at...FRAMINGHAM, Mass., Jan. 29 Cambridge Endo, a pion...le Port Access Laparoscopic Surgery or SPA) market...under, Woojin Lee, was among the industry leaders ...inic Medical Innovation Summit. Cambridge Endo de...
Other Biology Technology:InformexUSA 2009 Opens to Strong Attendance 2InformexUSA 2009 Opens to Strong Attendance 3InformexUSA 2009 Opens to Strong Attendance 4ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009 2Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009 2(Date:11/20/2009)...vember 19, 2009 The estimated 4.6 million America...of developing respiratory symptoms due to poor air...ire study undertaken earlier this year by investig...erinary Medicine. , The studywhich polled more t... percent of individuals working in barns complaine...
(Date:11/20/2009)... production of flax shives, and generated from Br...to those which engulf fields in spring, can be use...y two studies carried out by Spanish and Dutch res...nd Sustainable Energy Reviews . , "These studies ... production of bioethanol from two, as yet unexplo...
(Date:11/19/2009)...years ago, at the end of the last ice age, North A...ng such iconic creatures as mammoths, mastodons, c...gan their precipitous slide to extinction. , And...hose diversity of large animals equaled or surpass... now, an entirely novel ecosystem emerged as broad...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Flax and yellow flowers can produce bioethanol 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Can the relationship between doctors and drug companies ever be a healthy one 3F 52168 1Can the relationship between doctors and drug companies ever be a healthy one 3F 52168 2Laser technology creates new forms of metal and enhances aircraft performance 13107 1Laser technology creates new forms of metal and enhances aircraft performance 13107 2NYU physicists find way to explore microscopic systems through holographic video 13103 1NYU physicists find way to explore microscopic systems through holographic video 13103 2NYU physicists find way to explore microscopic systems through holographic video 13103 3...ent of Civil and Environmental Engineering suggest...y a major role in the health of large areas of oce...n the Dec. 25 issue of the Journal of Fluid Mechan...und aquatic plants and demonstrates the importance...his new understanding can be used to guide restora...
... Prostate Cancer Foundation, largely through the g...o four institutions, including Weill Cornell Medic...cancer. The gift is one of the largest-ever indivi...e multidisciplinary research team, created by the ... novel nanomedicine for prostate cancer that can b...
...ement and Budget evaluates R&D programs at the U.S...es using a questionnaire that asks about many aspe...OMB rates programs based on the answers, and an "i...uences for a program or agency. After having trou...nstrate efficiency, EPA asked the National Researc...
Other Biology News:River plants may play major role in health of ocean coastal waters 2Nanomedicine research for prostate cancer supported by $5 million gift 2Nanomedicine research for prostate cancer supported by $5 million gift 3Immobilized E. coli Lysate from Pierce Biotechnology, Inc.
EcoR I/Hind III End Modification Kit from Novagen
...gen and antibody-based immunoaffinity matrices, su...times without compromising antigen-antibody reacti...ts has precluded the application of these methods ...stern Blot Mild Antibody Stripping Solution contai...
ReBlot™ Western Blot Recycling Kit from Upstate
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |